Loading…

P592 Final results on immunogenicity profile and predictors of ADA development of biosimilar infliximab during the first 12 months of the therapy: results from a prospective nationwide cohort

Saved in:

Bibliographic Details
Published in:	Journal of Crohn's and colitis 2017-02, Vol.11 (suppl_1), p.S382-S382
Main Authors:	Lovasz, B.D., Kurti, Z., Rutka, M., Vegh, Z., Gecse, K.B., Farkas, K., Banai, J., Bene, L., Golovics, P.A., Gonczi, L., Gasztonyi, B., Kristof, T., Lakatos, L., Miheller, P., Palatka, K., Patai, A., Papp, M., Salamon, A., Szamosi, T., Szepes, Z., Toth, G.T., Vincze, A., Szalay, B., Molnar, T., Lakatos, P.L.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!